Company Description
Lifecore Injectables CDMO is a U.S.-based Contract Development and Manufacturing Organization specializing in the development, fill/finish, and commercialization of sterile injectable pharmaceuticals, biologics, medical devices, and combination products. With a 40+ year regulatory track record and 20+ commercial products, Lifecore offers end-to-end services including formulation process development, aseptic fill/finish, analytical services, packaging, and stability studies.
Additional highlights:
- Annex 1 compliant
- Isolator filling
- Global certifications and registrations
Company Background
Lifecore was founded in 1965 and has 400+ employees and annual revenues exceeding $125 million in recent fiscal years. Senior leadership includes (President and CEO) Paul Josephs, (Chief Financial Officer) Ryan D. Lake (CPA), (Chief Commercial Officer) Mark DaFonseca, and (Executive Vice President, Quality and Development Services) Jackie Klecker.
Facilities
Lifecore has a three-site campus (248,000 square feet) in the Minneapolis, MN metropolitan area. Operations include pilot laboratory for process development, aseptic formulation and fill/finish suites, redundant analytical laboratories, stability chambers, and secondary and final packaging.
Services and Capabilities
Lifecore offers end-to-end services including formulation process development, aseptic fill/finish, analytical services, packaging, and stability studies. Our capabilities span easy-to-complex formulations including expertise with highly viscous products (exceeding 100,000 cP). We provide support across pre-clinical, clinical, and commercial stages. Lifecore is also a leading producer of pharmaceutical-grade, non-animal-sourced sodium hyaluronate which is used as an API and excipient.